Please login to the form below

Not currently logged in
Email:
Password:

Rubica appoints former GSK executive communications and engagement lead

Caroline Gosling becomes Rubica’s director of culture and engagement

Caroline GoslinRubica has poached GlaxoSmithKline’s executive communications and engagement lead Caroline Gosling, who moves to the change management consultancy as its director of culture and engagement.

Gosling’s new role will see her lead Rubica’s capability in employee engagement, with a specific focus on creating the mindsets and cultural change needed for organisations to prevail.

She will also support leaders to create the organisational understanding, belief and behaviour shifts necessary for change to happen effectively and for the long term.

Gosling said: “I’m incredibly excited to be joining Rubica.

“They are a young, dynamic company tackling a fundamental issue in organisations - bridging the gap between strategy creation and the change required to implement that strategy.”

Prior to her new role, Gosling spent just under five years at pharma giant GlaxoSmithKline (GSK) in a range of business leadership roles across communications, employee engagement, multichannel marketing, government affairs and health policy.

Before her time with GSK, Gosling headed the communications practice at Virgo Health.

23rd March 2018

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Swordfish Advertising

At Swordfish Advertising, we believe building an effective brand shouldn't be stressful. Don't get us wrong; it takes blood, sweat...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics